Differential effects of SNARE-dependent gliotransmission on behavioral phenotypes in a mouse model of Huntington's disease

被引:5
|
作者
King, Annesha C. [1 ,2 ]
Wood, Tara E. [2 ]
Rodriguez, Efrain [2 ]
Parpura, Vladimir [3 ]
Gray, Michelle [2 ,3 ]
机构
[1] Univ Alabama Birmingham, Grad Biomed Sci Neurosci Theme, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
Huntington's disease; Full-length mutant huntingtin; Huntingtin; Astrocytes; Gliotransmission; BACHD; dnSNARE; MUTANT HUNTINGTIN; GLUTAMATE TRANSPORT; SECRETORY-CELLS; SEX-DIFFERENCES; IN-VIVO; ASTROCYTES; EXPRESSION; RELEASE; SYMPTOMS; R6/2;
D O I
10.1016/j.expneurol.2020.113358
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a dominantly inherited neurodegenerative disease caused by a polyglutamine expansion in the widely expressed huntingtin protein. Multiple studies have indicated the importance of mutant huntingtin (mHTT) in astrocytes to HD pathogenesis. Astrocytes exhibit SNARE-dependent exocytosis and gliotransmission, which can be hampered by transgenic expression of dominant negative SNARE (dnSNARE) in these glial cells. We used BACHD mice and crossed them with the dnSNARE model to determine if pan-astrocytic SNARE-dependent exocytosis plays an important role in vivo in the progression of HD behavioral phenotypes. We assessed motor and neuropsychiatric behaviors in these mice. At 12 months of age there was a significant improvement in motor coordination (rotarod test) in BACHD/dnSNARE mice when compared to BACHD mice. Analyses of open field performance revealed significant worsening of center entry (at 9 and 12 months), but not distance traveled in BACHD/dnSNARE when compared to BACHD mice, and variable/inconclusive results on vertical plane entry. While no differences between BACHD and BACHD/dnSNARE mice at 12 months of age in the forced swim test were found, we did observe a significant decrease in performance of BACHD/dnSNARE mice in the light-dark box paradigm. Thus, reduction of astrocytic SNARE-dependent exocytosis has differential effects on the psychiatric-like and motor phenotypes observed in BACHD mice. These data suggest broadly targeting SNARE-dependent exocytosis in astrocytes throughout the brain as a means to modulate gliotransmission in HD may contribute to worsening of specific behavioral deficits and perhaps a brain-region specific approach would be required.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
    Xi Chen
    Jun Wu
    Svetlana Lvovskaya
    Emily Herndon
    Charlene Supnet
    Ilya Bezprozvanny
    Molecular Neurodegeneration, 6
  • [32] ACMSD Provides Neuroprotection in a Mouse Model of Huntington's Disease
    Fink, K. D.
    Deng, P.
    Cameron, D.
    Brundin, L.
    Manfredsson, F. P.
    CELL TRANSPLANTATION, 2021, 30 : 5 - 6
  • [33] Therapeutic potential of erythropoietin in a mouse model of huntington's disease
    Rolfes, S.
    Boettcher, C.
    Priller, J.
    HUMAN GENE THERAPY, 2014, 25 (11) : A107 - A107
  • [34] Metformin therapy in a transgenic mouse model of Huntington's disease
    Ma, Thong C.
    Buescher, Jessica L.
    Oatis, Benjamin
    Funk, Jason A.
    Nash, Andrew J.
    Carrier, Raeann L.
    Hoyt, Kari R.
    NEUROSCIENCE LETTERS, 2007, 411 (02) : 98 - 103
  • [35] Striatal transplantation in a transgenic mouse model of Huntington's disease
    Dunnett, SB
    Carter, RJ
    Watts, C
    Torres, EM
    Mahal, A
    Mangiarini, L
    Bates, G
    Morton, AJ
    EXPERIMENTAL NEUROLOGY, 1998, 154 (01) : 31 - 40
  • [36] Minocycline is not beneficial in a phenotypic mouse model of Huntington's disease
    Diguet, E
    Rouland, R
    Tison, F
    ANNALS OF NEUROLOGY, 2003, 54 (06) : 841 - 842
  • [37] Cardiac Fas-Dependent and Mitochondria-Dependent Apoptotic Pathways in a Transgenic Mouse Model of Huntington's Disease
    Wu, Bor-Tsang
    Chiang, Ming-Chang
    Tasi, Ching-Yi
    Kuo, Chia-Hua
    Shyu, Woei-Cherng
    Kao, Chung-Lan
    Huang, Chih-Yang
    Lee, Shin-Da
    CARDIOVASCULAR TOXICOLOGY, 2016, 16 (02) : 111 - 121
  • [38] Cardiac Fas-Dependent and Mitochondria-Dependent Apoptotic Pathways in a Transgenic Mouse Model of Huntington’s Disease
    Bor-Tsang Wu
    Ming-Chang Chiang
    Ching-Yi Tasi
    Chia-Hua Kuo
    Woei-Cherng Shyu
    Chung-Lan Kao
    Chih-Yang Huang
    Shin-Da Lee
    Cardiovascular Toxicology, 2016, 16 : 111 - 121
  • [39] Altered Behavioral Responses to Gamma-Aminobutyric Acid Pharmacological Agents in a Mouse Model of Huntington's Disease
    Hsu, Yi-Ting
    Chang, Ya-Gin
    Chang, Ching-Pang
    Siew, Jian-Jing
    Chen, Hui-Mei
    Tsai, Chon-Haw
    Chern, Yijuang
    MOVEMENT DISORDERS, 2017, 32 (11) : 1600 - 1609
  • [40] Dysfunctional Behavioral Modulation of Corticostriatal Communication in the R6/2 Mouse Model of Huntington's Disease
    Hong, S. Lee
    Cossyleon, Desiree
    Hussain, Wajeeha A.
    Walker, Lauren J.
    Barton, Scott J.
    Rebec, George V.
    PLOS ONE, 2012, 7 (10):